Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04060394
Title Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Laekna Limited
Indications

prostate adenocarcinoma

Therapies

Afuresertib + LAE001 + Prednisone

Afuresertib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.